Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.

Second-line Pembrolizumab for Metastatic Urothelial Carcinoma: Differences in Treatment Outcomes According to the Primary Site.

Naotaka Nishiyama,Yuki Kita,Katsuhiro Ito,Minoru Kato,Shingo Hatakeyama,Yuto Matsushita,Sei Naito,Makito Miyake,Shotaro Nakanishi,Yoichiro Kato,Tadamasa Shibuya,Tetsutaro Hayashi,Hiroaki Yasumoto,Takashi Yoshida,Motohide Uemura,Rikiya Taoka,Hiroyuki Nishiyama,Takashi Kobayashi,Hiroshi Kitamura

ANTICANCER RESEARCH（2023）

Cited 0|Views12
Key words
Chemo-resistant urothelial carcinoma,pembrolizumab,upper tract urothelial carcinoma,lower tract urothelial carcinoma
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined